Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J McLachlan

Showing results (81-90 of 497) with videos related to

Pageof 50
Sort By:
Clinical Pharmacokinetics|January 25, 2019
Physiologically Based Pharmacokinetic Modelling of Hyperforin to Predict Drug Interactions with St John's WortJeffry Adiwidjaja, Alan V Boddy, Andrew J McLachlan
Clinical Pharmacology and Therapeutics|September 6, 2012
Influence of environmental and genetic factors on CYP1A2 activity in individuals of South Asian and European ancestryV Perera, A S Gross, A J McLachlan
Journal of Chromatography|September 18, 1991
High-performance liquid chromatographic separation of the enantiomers of hydroxychloroquine and its major metabolites in biological fluids using an alpha 1-acid glycoprotein stationary phaseA J McLachlan, S E Tett, D J Cutler
BMC Geriatrics|December 1, 2018
The deprescribing rainbow: a conceptual framework highlighting the importance of patient context when stopping medication in older peopleAdam Todd, Jesse Jansen, Jim Colvin, et al.
Journal of Homosexuality|December 23, 2014
Sense of belonging to specific communities and depressive symptoms among Australian gay menSimon Morris, Suzanne McLaren, Angus J McLachlan, et al.
American Journal of Pharmaceutical Education|April 3, 2018
A Scoping Review of Peer-led Education in Patient Safety TrainingRamesh L Walpola, Andrew J McLachlan, Timothy F Chen
Bioinformatics (Oxford, England)|March 13, 2010
Integrative mixture of experts to combine clinical factors and gene markersKim-Anh Lê Cao, Emmanuelle Meugnier, Geoffrey J McLachlan
Methods in Molecular Biology (Clifton, N.J.)|November 30, 2016
ClusteringG J McLachlan, R W Bean, S K Ng
Clinical and Translational Science|April 29, 2025
Inter-Ethnic Differences in the Efficacy and Safety of Tyrosine Kinase Inhibitors Used in Oncology: Insights From Phase 3 Clinical TrialsNicki M Kyriacou, Annette S Gross, Andrew J McLachlan
Clinical Pharmacology and Therapeutics|February 23, 2020
The Effects of Cruciferous Vegetable-Enriched Diets on Drug Metabolism: A Systematic Review and Meta-Analysis of Dietary Intervention Trials in HumansShane K Eagles, Annette S Gross, Andrew J McLachlan
Pageof 50

Showing results (81-90 of 497) with videos related to

Sort By:
Pageof 50
Clinical Pharmacokinetics|January 25, 2019
Physiologically Based Pharmacokinetic Modelling of Hyperforin to Predict Drug Interactions with St John's WortJeffry Adiwidjaja, Alan V Boddy, Andrew J McLachlan
Clinical Pharmacology and Therapeutics|September 6, 2012
Influence of environmental and genetic factors on CYP1A2 activity in individuals of South Asian and European ancestryV Perera, A S Gross, A J McLachlan
Journal of Chromatography|September 18, 1991
High-performance liquid chromatographic separation of the enantiomers of hydroxychloroquine and its major metabolites in biological fluids using an alpha 1-acid glycoprotein stationary phaseA J McLachlan, S E Tett, D J Cutler
BMC Geriatrics|December 1, 2018
The deprescribing rainbow: a conceptual framework highlighting the importance of patient context when stopping medication in older peopleAdam Todd, Jesse Jansen, Jim Colvin, et al.
Journal of Homosexuality|December 23, 2014
Sense of belonging to specific communities and depressive symptoms among Australian gay menSimon Morris, Suzanne McLaren, Angus J McLachlan, et al.
American Journal of Pharmaceutical Education|April 3, 2018
A Scoping Review of Peer-led Education in Patient Safety TrainingRamesh L Walpola, Andrew J McLachlan, Timothy F Chen
Bioinformatics (Oxford, England)|March 13, 2010
Integrative mixture of experts to combine clinical factors and gene markersKim-Anh Lê Cao, Emmanuelle Meugnier, Geoffrey J McLachlan
Methods in Molecular Biology (Clifton, N.J.)|November 30, 2016
ClusteringG J McLachlan, R W Bean, S K Ng
Clinical and Translational Science|April 29, 2025
Inter-Ethnic Differences in the Efficacy and Safety of Tyrosine Kinase Inhibitors Used in Oncology: Insights From Phase 3 Clinical TrialsNicki M Kyriacou, Annette S Gross, Andrew J McLachlan
Clinical Pharmacology and Therapeutics|February 23, 2020
The Effects of Cruciferous Vegetable-Enriched Diets on Drug Metabolism: A Systematic Review and Meta-Analysis of Dietary Intervention Trials in HumansShane K Eagles, Annette S Gross, Andrew J McLachlan
Pageof 50